Evaluation of the "cognitive reserve" which modifies progression of Alzheimer disease using Multimodal Neuroimaging

Evaluation of the "cognitive reserve" which modifies progression of Alzheimer disease using Multimodal Neuroimaging - Multimodal Neuroimaging for AD diagnosis (MULNIAD)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000006419

Enrollment

100

Registered

2011-10-01

Start date

2011-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer disease (AD) Mild cognitive impairment (MCI)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: normal Amnestic MCI Alzheimer disease

Exclusion criteria

Exclusion criteria: Significant neurological or psychiatric disease Neurological abnormality Psychiatric symptom

Design outcomes

Primary

Measure	Time frame
Visualization of cognitive reserve Detection of functional surrogate markers for Alzheimer disease	—

Countries

Japan

Contacts

Public ContactAkinori Nakamura

National Center for Geriatrics and Gerontology Department of Clinical and Experimental Neuroimaging

nakamura@ncgg.go.jp0562-46-2311

Outcome results